Consolidated Statements of Shareholder's Equity - USD ($) $ in Thousands	Total	Capital Stock [Member]	Other Equity [Member]	Statutory Surplus Reserve [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Non-controlling Interests [Member]	Common Shares Issued and Outstanding [Member]
Balance, beginning of year at Dec. 31, 2020		$ 407,020	$ 188,845		$ (202,849)	$ 988
Movement of Shareholders' Equity
Amortization of share-based payment expense - stock options			1,267
Amortization of share-based payment expense - restricted share units			17,116
Amortization of share-based payment expense - performance stock units			5,733
Change in shares held in treasury		11
Restricted share units vested		9,833	(14,740)
Employee stock options exercised, net of shares withheld for employee tax obligations		883
Grant date fair value of stock options exercised		271	(271)
Change in ownership interest related to IMAX China common share repurchases			(4,263)				$ (5,797)
Purchase of capped calls related to convertible notes			(19,067)
Common shares repurchased and retired		(8,039)			(5,865)
Net Income (Loss)	$ (22,329)				(22,329)
Net income attributable to non-controlling interests	12,752						12,753
Other comprehensive (loss) income, net of tax	2,550					1,539
Other comprehensive (loss) income, net of tax							1,011
Share-based compensation attributable to non-controlling interests							449
Establishment of statutory surplus reserve, IMAX China				$ 3,932			1,699
Statutory surplus reserve deducted from retained earnings, IMAX China					(3,932)
Dividends paid to non-controlling shareholders of IMAX China							(4,889)
Balance, end of year at Dec. 31, 2021		409,979	174,620	3,932	(234,975)	2,527
Balance, beginning of year at Dec. 31, 2020							70,004
Movement of Shareholders' Equity
Statutory surplus reserve deducted from IMAX China retained earnings							(1,699)
Balance, end of year at Dec. 31, 2021							73,531
Common shares issued and outstanding, Balance, beginning of year at Dec. 31, 2020								58,921,008
Movement of Shareholders' Equity
Employee stock options exercised								41,613
Restricted share units and stock option exercises settled from treasury shares purchased on open market								723
Restricted share units settled with new treasury shares								531,629
Repurchase of common shares								(841,331)
Common shares issued and outstanding, Balance, end of year at Dec. 31, 2021								58,653,642
Movement of Shareholders' Equity
Total shareholders' equity	429,614
Amortization of share-based payment expense - stock options			637
Amortization of share-based payment expense - restricted share units			18,952
Amortization of share-based payment expense - performance stock units			8,495
Restricted share units vested		11,597	(16,441)
Issuance of common shares in acquisition		1,947						$ 160,547
Change in ownership interest related to IMAX China common share repurchases			(585)				(2,458)
Common shares repurchased and retired		(46,808)			(35,349)
Net Income (Loss)	(22,800)				(22,800)
Net income attributable to non-controlling interests	2,923						2,959
Other comprehensive (loss) income, net of tax	(18,300)					(12,373)
Other comprehensive (loss) income, net of tax							(5,927)
Share-based compensation attributable to non-controlling interests							290
Dividends paid to non-controlling shareholders of IMAX China							(2,704)
Balance, end of year at Dec. 31, 2022	263,355	376,715	185,678	3,932	(293,124)	(9,846)
Balance, end of year at Dec. 31, 2022	$ 65,691						65,691
Movement of Shareholders' Equity
Restricted share units settled with new treasury shares								596,277
Repurchase of common shares								(5,261,852)
Common shares issued and outstanding, Balance, end of year at Dec. 31, 2022	54,148,614							54,148,614
Movement of Shareholders' Equity
Total shareholders' equity	$ 329,046
Amortization of share-based payment expense - stock options			93
Amortization of share-based payment expense - restricted share units			12,502
Amortization of share-based payment expense - performance stock units			8,321
Restricted share units vested		13,701	(21,074)
Change in ownership interest related to IMAX China common share repurchases			(433)				418
Common shares repurchased and retired		(1,368)			(25,056)
Net Income (Loss)	25,335				25,335
Net income attributable to non-controlling interests	7,731						7,793
Other comprehensive (loss) income, net of tax	(3,337)					(2,235)
Other comprehensive (loss) income, net of tax							(1,102)
Share-based compensation attributable to non-controlling interests							428
Dividends paid to non-controlling shareholders of IMAX China							(1,438)
Balance, end of year at Dec. 31, 2023	273,141	$ 389,048	$ 185,087	$ 3,932	$ (292,845)	$ (12,081)
Balance, end of year at Dec. 31, 2023	$ 71,790						$ 71,790
Movement of Shareholders' Equity
Performance stock units settled with new treasury shares								233,306
Restricted share units settled with new treasury shares								514,383
Repurchase of common shares								(1,636,027)
Common shares issued and outstanding, Balance, end of year at Dec. 31, 2023	53,260,276							53,260,276
Movement of Shareholders' Equity
Total shareholders' equity	$ 344,931